Clinical Trials Browser

Phase 3 × Recurrence × Azacitidine × Clear all

NCT03765541 2025-04-10

DEXAML-03

Phase 3 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

NCT04722952 2021-12-03

PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute